MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Cash and cashequivalents$55,003K Prepaid expenses andother current assets$4,002K Restricted cash$194K Total property andequipment, gross$1,410K Total current assets$59,199K Other assets$3,801K Operating leaseright-of-use assets$1,303K Property and equipment,net$457K Less accumulateddepreciation$953K Total assets$64,760K Accumulated deficit-$291,889K Total liabilities,redeemable convertible...$64,760K Total stockholders'deficit-$276,080K Additional paid-in capital$15,809K Redeemable convertiblepreferred stock$288,582K Total liabilities$52,258K Total currentliabilities$51,575K Operating leaseliabilities, non-current$648K Other long-termliabilities$35K Convertible promissorynotes$29,897K Accrued expenses andother current...$12,259K Derivative liability$5,148K Accounts payable$3,566K Operating leaseliabilities, current$705K
Balance Sheet

Latigo Biotherapeutics, Inc. (LTGO)

Latigo Biotherapeutics, Inc. (LTGO)

source: myfinsight.com